Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2026-03-12 @ 12:41 AM
Study NCT ID:
NCT03272633
Status:
TERMINATED
Last Update Posted:
2023-06-26
First Post:
2017-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Sponsor:
Rutgers, The State University of New Jersey
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Lymphoblastic Leukemia | View |
| None | Acute Myeloid Leukemia in Remission | View |
| None | Hematopoietic Cell Transplantation Recipient | View |
| None | JAK2 Gene Mutation | View |
| None | Loss of Chromosome 17p | View |
| None | Mantle Cell Lymphoma | View |
| None | Minimal Residual Disease | View |
| None | Myelodysplastic Syndrome | View |
| None | Non-Hodgkin Lymphoma | View |
| None | Plasma Cell Myeloma | View |
| None | RAS Family Gene Mutation | View |
| None | Recurrent Diffuse Large B-Cell Lymphoma | View |
| None | Recurrent Hematologic Malignancy | View |
| None | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | View |
| None | Refractory Diffuse Large B-Cell Lymphoma | View |
| None | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | View |
| None | Therapy-Related Acute Myeloid Leukemia | View |
| None | Therapy-Related Myelodysplastic Syndrome | View |
| None | TP53 Gene Mutation | View |
Keywords: